224 related articles for article (PubMed ID: 35094954)
1. We'll always have Paris The Paris System for Reporting Urinary Cytology 2022.
Wojcik EM; Kurtycz DFI; Rosenthal DL
J Am Soc Cytopathol; 2022; 11(2):62-66. PubMed ID: 35094954
[TBL] [Abstract][Full Text] [Related]
2. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
[TBL] [Abstract][Full Text] [Related]
3. Are we on track for diagnosing high-grade urothelial carcinoma with a minimum quantity of five malignant cells in lower tract specimens? Critical analysis of The Paris System Quantitation Criteria.
Folarin OS; Siddiqui MT
Cancer Cytopathol; 2023 Nov; 131(11):708-715. PubMed ID: 37572083
[TBL] [Abstract][Full Text] [Related]
4. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
5. The Paris system of Reporting Urinary Cytology: Strengths and opportunities.
Kurtycz DFI; Sundling KE; Barkan GA
Diagn Cytopathol; 2020 Oct; 48(10):890-895. PubMed ID: 32780564
[TBL] [Abstract][Full Text] [Related]
6. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
[TBL] [Abstract][Full Text] [Related]
7. The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
Yamasaki M; Taoka R; Katakura K; Matsunaga T; Kani N; Honda T; Harada S; Tohi Y; Matsuoka Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Haba R; Sugimoto M
BMC Urol; 2022 Apr; 22(1):51. PubMed ID: 35382830
[TBL] [Abstract][Full Text] [Related]
8. The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
Moulavasilis N; Stravodimos K; Meletis E; Levis P; Leftheriotis V; Lazaris A; Constantinides C; Mikou P
Diagn Cytopathol; 2022 Jun; 50(6):289-294. PubMed ID: 35262275
[TBL] [Abstract][Full Text] [Related]
9. Cyto-histo correlation and false-negative urine: Before and after the Paris system for reporting urinary cytology.
Yuan L; Gero M; Zia S; Aryal SC; Shetty S; Reynolds JP
Diagn Cytopathol; 2022 Aug; 50(8):404-410. PubMed ID: 35652594
[TBL] [Abstract][Full Text] [Related]
10. Urinary tract cytology showing variant morphology and divergent differentiation.
Arshia A; Hassan FA; Hensley PJ; Allison DB
Cytopathology; 2024 Mar; 35(2):199-212. PubMed ID: 37919868
[TBL] [Abstract][Full Text] [Related]
11. Atypical urothelial cells classified according to the Paris System for Reporting Urinary Cytology: A 2-year experience with histological correlation from a Finnish tertiary care center-low rate and high risk of malignancy.
Pöyry E; Nykänen V; Pulkkinen J; Viljanen E; Laurila M; Kholová I
Cancer Cytopathol; 2023 Sep; 131(9):574-580. PubMed ID: 37246298
[TBL] [Abstract][Full Text] [Related]
12. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
[TBL] [Abstract][Full Text] [Related]
13. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
Anbardar MH; Monjazeb R
Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
[TBL] [Abstract][Full Text] [Related]
14. Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features.
Suh J; Go H; Sung C; Baek S; Hwang H; Jeong S; Cho Y
Cytopathology; 2017 Dec; 28(6):516-523. PubMed ID: 28816366
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Implementation and Diagnostic Accuracy of the Paris Classification for Reporting Urinary Cytology in Voided Urine Specimens: A Cyto-Histological Correlation Study in a Cancer Center.
Lobo J; Lobo C; Leça L; Rodrigues Â; Henrique R; Monteiro P
Pathobiology; 2023; 90(4):233-240. PubMed ID: 36574757
[TBL] [Abstract][Full Text] [Related]
16. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
Celik B; Kavas G
Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
[TBL] [Abstract][Full Text] [Related]
17. The inclusion of nuclear area improves the Paris system for reporting urinary cytology.
Tanaka S; Naritomi M; Monobe Y; Ariyasu S
Cytopathology; 2023 Mar; 34(2):106-112. PubMed ID: 36336883
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Paris System in atypical urinary cytology.
Mikou P; Lenos M; Papaioannou D; Vrettou K; Trigka EA; Sousouris S; Constantinides C
Cytopathology; 2018 Dec; 29(6):545-549. PubMed ID: 30066427
[TBL] [Abstract][Full Text] [Related]
19. Application of The Paris System in neobladder washing cytology: Comparison between the original diagnosis and correlation with histopathology.
Kim JM; Lee J; Sung SH
Diagn Cytopathol; 2023 Dec; 51(12):744-750. PubMed ID: 37610033
[TBL] [Abstract][Full Text] [Related]
20. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
